Vivani Medical, Inc. (VANI)
NASDAQ: VANI · IEX Real-Time Price · USD
1.250
0.00 (0.00%)
At close: Jul 26, 2024, 4:00 PM
1.260
+0.010 (0.80%)
After-hours: Jul 26, 2024, 7:59 PM EDT
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
44
Market Cap
68.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Burning Rock Biotech | 72.30M |
Theratechnologies | 60.71M |
Precision BioSciences | 57.53M |
Champions Oncology | 50.16M |
Gritstone bio | 15.65M |
Celularity | 14.79M |
VANI News
- 15 days ago - Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 - Business Wire
- 6 weeks ago - Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant - Business Wire
- 2 months ago - Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant - Business Wire
- 2 months ago - Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - Vivani Medical to Present at TIDES Conference 2024 - Business Wire
- 4 months ago - Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 5 months ago - Vivani Medical Appoints Daniel Bradbury to its Board of Directors - Business Wire
- 5 months ago - Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants - Business Wire